Free Trial

Viridian Therapeutics (VRDN) SEC Filings & 10K Form

Viridian Therapeutics logo
$14.44 -0.23 (-1.57%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$14.44 0.00 (-0.03%)
As of 03/28/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Viridian Therapeutics SEC Filings

DateFilerForm TypeView
03/12/2025
3:27 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:36 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:17 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:19 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:12 PM
Harmon Seth (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:13 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:14 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:17 PM
Tousignant Jennifer (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
03/03/2025
3:35 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:33 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:05 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:22 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:52 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:53 PM
Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
11:33 AM
STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
09/30/2024
6:12 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:10 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:07 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/12/2024
4:25 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:28 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/10/2024
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:25 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:01 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:31 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:25 PM
Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:16 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:05 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
05/08/2024
6:51 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
7:30 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:30 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:32 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/26/2024
7:32 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

04/26/2024
7:34 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/26/2024
7:34 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/01/2024
5:38 PM
Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
04/01/2024
5:32 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VRDN) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners